follicular lymphoma News
Most Popular follicular lymphoma Story
Rituxan tests positive in Phase III trial
Rituxan got out of school early by completing the requirements of a Phase III trial during an early analysis. Follicular lymphoma patients who received the drug alone following its use with... Read more...
Latest Headlines
- September 17, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
